Lord, Abbett & Co’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-787,028
| Closed | -$33.7M | – | 625 |
|
|
2019
Q4 | $33.7M | Buy |
787,028
+170,419
| +28% | +$7.29M | 0.11% | 285 |
|
|
2019
Q3 | $22.2M | Buy |
+616,609
| New | +$22.2M | 0.08% | 386 |
|
|
2017
Q2 | – | Sell |
-253,673
| Closed | -$8.72M | – | 873 |
|
|
2017
Q1 | $8.72M | Sell |
253,673
-25,800
| -9% | -$887K | 0.03% | 637 |
|
|
2016
Q4 | $8.06M | Sell |
279,473
-885,811
| -76% | -$25.5M | 0.02% | 631 |
|
|
2016
Q3 | $37.1M | Sell |
1,165,284
-1,026,169
| -47% | -$32.6M | 0.11% | 286 |
|
|
2016
Q2 | $71.1M | Buy |
2,191,453
+2,126,453
| +3,271% | +$69M | 0.22% | 133 |
|
|
2016
Q1 | $1.82M | Sell |
65,000
-530,723
| -89% | -$14.8M | 0.01% | 836 |
|
|
2015
Q4 | $21.2M | Sell |
595,723
-98,506
| -14% | -$3.51M | 0.06% | 412 |
|
|
2015
Q3 | $23M | Sell |
694,229
-273,869
| -28% | -$9.06M | 0.07% | 382 |
|
|
2015
Q2 | $40.5M | Buy |
968,098
+584,339
| +152% | +$24.5M | 0.11% | 307 |
|
|
2015
Q1 | $12.5M | Sell |
383,759
-905,850
| -70% | -$29.5M | 0.03% | 578 |
|
|
2014
Q4 | $40.9M | Sell |
1,289,609
-488,609
| -27% | -$15.5M | 0.1% | 275 |
|
|
2014
Q3 | $44M | Buy |
1,778,218
+678,797
| +62% | +$16.8M | 0.11% | 259 |
|
|
2014
Q2 | $24.8M | Buy |
1,099,421
+200,368
| +22% | +$4.53M | 0.06% | 473 |
|
|
2014
Q1 | $21.9M | Sell |
899,053
-86,892
| -9% | -$2.11M | 0.05% | 483 |
|
|
2013
Q4 | $24.6M | Sell |
985,945
-716,073
| -42% | -$17.9M | 0.05% | 473 |
|
|
2013
Q3 | $46.8M | Sell |
1,702,018
-418,652
| -20% | -$11.5M | 0.11% | 277 |
|
|
2013
Q2 | $38.5M | Buy |
+2,120,670
| New | +$38.5M | 0.09% | 340 |
|